in this issue
Regions :: Western Europe
Fine and Custom Chemicals
February 7, 2007 | Alex Scott in Zurich
Pharmaceutical manufacturers often produce drugs using hazardous materials and high temperatures, and their manufacturing processes frequently generate significantly more by-product than the final drug product itself. Sustainable manufacturing historically has not been a priority for the sector, analysts say. This is changing, however, due to: rising raw material prices; increasing pressure to reduce costs; and growing pressure from environmental groups and regulators on pharma and chemical companies to adopt sustainable manufacturing practices. Western pharma...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee